OpGen expands AEI Capital equity line from $3M to $9M; period extended to Dec 2025

CapForce Inc.

Amendment dated Oct 3, 2024 increases maximum common stock sale to AEI Capital from $3M to $9M.
Two additional $3M tranches available after initial $3M; shares sold in $1M or $2M increments.
Company's right to sell stock extended to Dec 31, 2025 (was Sep 30, 2024).
Sale will be unregistered under Section 4(a)(2), Regulation D and S.
John Tan Honjian signed as President of AEI Capital and Chairman/CEO of OpGen.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.